MALNUTRITION IN HOSPITALIZED ELDERS: A PROSPECTIVE STUDY OF ITS PREVALENCE AND ASSOCIATION WITH MORTALITY KE Covinsky, G Martin, CS
Laedefeld. University Hospitals, Cleveland VAMC, Case Western Reserve University, Cleveland, OH While anecdotal evidence suggests that malnutrition is common in elder people with medical illness, few studies have systematically assessed the prevalence or outcomes of malnutrition in these patiants (PTS). We systematically asseased the nutritional status of 296 general medical PTS (age > 70) using the Subjective Global Assessment of Detsky (SGA), a validated measure of nutritional statns. The SGA is a systematic method of obtaiinog a nutrition-oriented history (such as weight less and dietary change), physical exam (such as muscle wasting, subcutaneous tissue loss), and applying clinical judgment to assign PTS to one of three nutritional classes: Severely malnourished (generally _> 10% weight loss ever past six months with marked physical signs of malnutrition), moderately malnourished (generally 5-10% weight loss with moderate physical signs of malnutrition), or well nourished. Nutrition exams were performed by either an MD or RN who had excellent interrater agreement (weighled Kappa=.83, 95% C1=.61-1.0). Additional covariates measured on admission included the number of dopendenl ADL and IADL (patient or surrogate interview) and the number of depressive symptoms on the modified 20-item CES-D (patient interview).
The mean age of the 296 PTS was 80.0, 61% were women, and 40% were nonwhite. 40% ef PTS were malnourished (15% severe, 25% moderate). On hospital admission, malnourished PTS were dependent in more ADL (mean, 3.0 and 2.5 in severely and moderately malnourished PTS vs. 2.0 in well nourished PTS, p<.05), dependent in mum IADL (5.2 and 4.7 vs 3.8, p<.01), and had mum depressive symptoms (7.2 and 5.3, vs 4.5, p<.01). 90 day mortality was 30~ 22~ and 10% (p<.01) in severely malnourished, moderately malnourished, and well nourished PTS, respectively. After controlling for demographics and admission ADL function in a logistic regression model, 90 day mortality was higher in PTS with moderate malnutrition (OR=2.5, 95% CI=1.2-5.2) or severe malnutrition (OR=3.8, 1.7-85). We conelucle that malnutrition is common in hospitalized older people, is associated with functianal dependency and depression, and is a risk factor for 90 day mortality EFFECTS OF COENZYME A REDUCTASE INHIBITORS ON STROKE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. I-1C Bueber, LE Griffith, GH Guyatt, Department of Internal Medicine, University Hospital Basel, Switzerland, Department of Clinical Epidemiology & Biostatisties, McMaster University Hamilton, Ontario, Canada.
Stroke is one of the leading eanses of death, and hypercholesterolemia may be a risk factor. We investigated whether cholesterol reduction with coenzyme A reduetase inhibitors or other antilipidemie interventions reduces the risk of non-fatal and fatal stroke.
We conducted a systematic literature search and included all randomised controlled trials of any cholesterol lowering intervention that reported data on non-fatal and fatal strokes. Trials were combined using a random effect model. We then investigated whether treatment effects differed according to the type of ehulesterol lowering intervention.
We included 27 trials with 46,676 study Farticipants in the intervention and 53,869 in the control group. The risk ratio of non-fatal and fatal stroke for all trials was 0.95 (95% CI 0.86 to 1.05, test of heterogeneity p-N).83). For coenzyme A reduetase inhibitors the risk ratio of non-fatal and fatal stroke was 0.76 (95% CI 0.62 to 0.92, test of heterogeneity p=0.gs) an estimate which was statistically significantly different (p-~).02) from all other interventions(risk ratio 1.06, 95%CI 087 to 1.31) Dietary and other cholesterol lowering interventions had no effect on the incidence of non-fatal and fatal stroke. For coenzyme A reduetase inhibitors we also found a statistically significant reduction of coronary heart disease and overall mortality This analysis suggests a causal role of cholesterol in the pathogenesis of stroke. Coenzyme A reduetase inhibiturs reduce the incidence of non-fatal and fatal stroke and reduce eoronal~y heart disease and overall mortality PROGNOSTIC VALUE OF THE CLINCIAL EXAMINATION OF THE DIABETIC FOOT ULCER. David Edelman, David M Hough, Katrina N Glazebrook, and Eugene Z Oddone, Durham Veterans Affairs Medical Center, Durham, NC We sought to determine the value of the history, physical examination, and Magnetic Resonance Imaging (MRI) in predicting successful primary healing of foot ulcers in diabetic patients. Sixty-four consecutive diabetic patients presenting to the outpatient or emergency department with 78 dermal ulcers through the full thiekneas oftbe skin and at or distal to the malleoli of the ankle received a structured clinical history and physical examination performed both by a physician participating in the study and the referring physician. Fifty of these patients with 63 ulcers underwent MRI of the affected foot. Patients were followed prospectively for six months after enrollment to ascertain healing of the ulcer, amputation, and death. During the six month follow-up period, g ( ! 3%) patients died. There were 13 (17%) amputations, 17 (22%) additional ulcers failed to heal, and 36 (47%) healed without amputalion. Univarlate predictors of adverse outcome (non-healing, amputation or death) at 6 months included age more than 65, diagnosis of diabetes more than 15 years ago, painful ulcer, absent posterior tibial pulse, anklebraehial index less than 0.5, and the physician's assessment that the ulcer had a moderate or high likelihood of osteomyelitis. In a multivariable logistic model, predictors of adverse outcome were the absence of an audible pulse on Doppler examination (Odds Ratio 8.46, 95% CI 1.54, 46.5) and a painful ulcer (OR 3.69, 95% CI 1.03, 13.2) . The diagnosis of osteomyelitis on MR/did not predict ulcer outcome. Foot ulcers in patients with diabetes frequently have poor outcomes; fewer than half the patients in tiffs study healed their ulcers within 6 months. The vascular components of the clinical examination are the best predictors of healing in patients with a diabetic foot ulcer. It is unknown at what level of hemoglobin transfusion is indicated in surgical patients. We evaluated the effect of pert-operative transfusion on 30 and 90<lay postoperative mortality in a retrospective cohort study of 8,787 consecutive hip fracture patients, age 60 or older, who underwent surgical repair at 20 US hospitals between 1983 and 1993. The primary outcome was 30 day postoperative mortality. Secondary outcome was 90 day mortality. The "trigger" hemoglobin level was defined as the lowest hemoglobin level prior te the first transfusion during the time period or, for patients in the non-transfused group, as the lowest hemoglobin level during the time period.
INFLUENCE OF PERIOPERATWE BLOOD TRANSFUSION ON POSTOPERATIVE
The mean age was 80.3 (standard deviation=8.7, range 60-106) . 43 1% of patients had cardiovascular disease. The 30<lay mortality was 4.6% (N--402), 95% CI, 4.2%-5.0%. The 90-day mortality was 9.0% (N=788), 95% confidence interval (CI), 8.4%-9.6%. Forty-two percent of patients (N=3699) received a postoperative transfusion. Them was significant variation in transfusion practice among patients with trigger hemoglobin levels between 8.0 and 10.0 gnffdl, but 90% of patients with hemoglobin levels less than 8 gm/dl received postoperative transfusions. Postoperative transfusion did not influence 30 or 90 day mortality after adjusting for trigger hemoglobin level, cardiovascular disease, and mgny other risk factors for death; 30 day analysis: adjusted odds ratio---0.96; 95% CI, 0.74-126. 90 day urinalysis: adjusted hazard ratio=l.08; 95% CI, 0.90-1.29. The results were similar in the preoperative transfusion analysis.
Withholding perinperative transfusion in patients with hemoglobin levels g g/dl or higher did not appear to increase the risk of short or long term death in this elderly population. Below 8 g/dl, the estimate of the effect of transfusion is too imprecise to draw firm conulusions from this study.
ACCURACY OF THE PHYSICAL EXAMINATION FOR AORTIC STENOSIS. EE Etehatls, V Glenns, S Shadowilz, C Bell and S Sin, Divisions of General Intemul Medicine and Cardiology, The Toronto Hcepital, Department of Medicine, University of Tomato, Tomato, Canada, BACKGROUND: Detecting aortic steaosis is an important task for general internists, pa~icnlarly during prsopomtive assessment. Previnus studies of the accurary of the physical exanunalinn for detecting aortic stenosis have included only cardiologists or senior cardiology trainees.
OBJECTIVE: To evaluate the accuracy of the physical exanuuation by non~mfiologists for ruling-in and riding-out moderate to severe aorfir stenosis. DESIGN: Cross-sectinual study PARTICIPANTS: Consecutive inpatieats (n=123) from medical and cardiac wards referred for echecardiography. Exclusion criteria were age less than 50, rcceat MI or unstable angina, recent cardiac surgery, prosthetic valves, ICU or CCU admission, or severe respiratory distresa.
MAIN MEASURES: Each participant was examined independently by a general internist and a third year medical resident who were unaware of echecardingram results. In advance, we specified that absence of a murmur over the right clavicle would role-out aortic stenosis, and the presence of at least 3 of the following signs would rule-in aortic stenosis: slow upet roke of the carotid artery pulsation, reduced volume of the camlid artery pulsation, reduced intensity of the second heart sound, and maximal murmur intensity in the s~ond right intero~tal space. OUTCOME: Moderate (peak gradient 25-49 nun Hg, or valve area of 0.7-1.2 sq. cml or severe (peak gradient 50 nun Hg or mum, or valve area of less than 0.7 so.. era ) aortic stenosis on echecardingrapby. Echecardingrams were interpreted by a cardiologist without knowledge of the study exammarions. RESULTS: Sixtenapatieras(13%)hadmedemteersevereaorticstenosis. Absanceofamurmurover the right clavicle had a likelihood ratio efO. I0 (95% C! 0.02-0.43).while the preseace of at least 3 findings had a likelihood ratio of 39 (95% CI 6.6-240). A murmur over the light clavicle ~seciated with 0-2 findings was indetermiuate (likelihuad ratio LS, P0rpgse: To assess whether a coexisting anxiety disorder predicts persistent depressive illness at 12 months in a primary care setting.
Methods: Within a larger study of depression in a university-bused family practice clinic, patients meeting criteria for Major Depression were followed quarterly for one year. All psychiatric diagnoses were assessed with the Diagnostic Interview Schedule (DSM-IH-R version). Presence of an anxiety disorder (Panic Disorder, Generalized Anxiety Disorder, Social Phobia, and/or Agoraphobia) was identified at baseline, as were other possible predictors such as depression severity and medical illness severity, which have been shown to be prognostic factors in previous studies. The primary outcome was persistence of a depressive diagnosis (Major Depression, Dysthymia, or Minor Depression) at 12 months.
Results: Of 85 patients with Major Depression at baseline, 43 had a coexisting anxiety disorder; Social Phobia, an anxiety disorder neglected in previous studies of depression outcome, was the most common anxiety diagnosis (88%). Padents with and without coexisting anxiety disorders were similar in demographic characteristics, medical illness severity and depression severity. The risk for persistent depressive illness at 12 months was 82% in the group with a coexisting anxiety disorder and was 57% in the group without one (Risk Ratio=l.44 Blood cultures obtained from febrile oncelogy patients often yield negative or false-positive results due the low threshold for performing cultures. We developed a model to stratify patients at high or low risk for bacteremia. In a prospective cohort study, clinical data that might predict bacteremia were collected before culture results were known. Culture results (primary endpoint), changes in therapy, outcome of hospitalization, and length of stay data were collected by chart review. Univariate and multivariate analysis were used to identify risk factors for bacteremia. Results: 1655 episodes in 506 patients were evaluated. 83 cultures were positive and 1572 negative, with 22 determined to be false-positives.. Multivariate regression analysis yielded the following independant predictive factors: temperature, antibiotic use, clinical suspicion, malignancy type, central venous access, presence of infection, and first or second episode of evaluatiou (compared with others). Using these factors, risk groups can be identified with high (35%, n=~), intermediate (6%, n=140) and low (1%, n=265) rates of bacteremia. The high-risk group eharacteristins were temperature of >101.5, site of infection, and lack of antibiotics. Low-tisk group characteristics were temperature <101.5, use of any antibiotics, no infectious source, and two previously evaluated negative episodes, hi the low risk group, there were no alterations in therapy based on culture results. 18 percent of all culture episodes could be eliminated if cultures were withheld in the low-risk group in favor of further observation. Using a relatively simple clinical algorithm as an adjunct to clinical judgment, we can predict when patients are at high and low risk for bacteremin. Once validated, this model may allow more appropriate use of resources and improved patient outcomes by changing our utilization of blood cultures. Perioperative cardiac complications are a common cause of morbidity and mortality in patients undergoing noncardiac surgery. Cardiac risk is often evaluated preoperatively using the methods of Goldman er al or Detsky et al, as well as with the scale of the American Society of Anesthesiology (ASA). The Canadian Cardiovascular Society (CCS) rating of angina severity may also be used as a simple marker for cardiac risk. The purpose of this study was to prospectively compare these methods of cardiac risk assessment.
PROSPECTIVE EVALUATION OF DIFFERENT CARDIAC RISK
Methods: Elective and urgent adult surgical patients undergoing noneardiac surgery, and who were referred for a preoperative medical consultation were eligible for enrollment. Data were collected on all variables required to compute cardiac risk using existing methods. Patients were followed by their medical consultant until discharge, and all cardiac complications were recorded. Receiver operating characteristic (ROC) curves were constructed for each scale.
Results: 1515 patients were enrolled. The overall incidence of major cardiac events (MI, pulmonary edema or death) was 6.1%, and varied significantly with increasing age, prior MI, recent unstable angina, signs or history of heart failure, significant aortic stenosis, poor general medical status, and emergency surgery. Greater predicted cardiac risk on all four scales was associated with significantly greater cardiac event rates. The areas under the ROC curves for the methods of Goldman et al, Detsky et al, ASA and CCS were .72, .75, .67 and .72, respectively. There was no statistically significant difference among the ROC curve areas.
Conclusions: All existing methods of cardiac risk assessment are useful, but none shows definite superiority over the others in this investigation. Given that the CCS rating of angina is by far the easiest method to use it may be sufficient to use this alone for many patients undergoing noncardiac surgery. Nevertheless, since CCS does not account for patients who have severe congestive heart failure or valvular heart disease, these patients may require more intensive preoperative evaluation.
POSTMENOPAUSAL ESTROGENS AND THE RISK OF OVARIAN CANCER. P Garg, K Kerlikowske, D Grady, and L Suhak, Division of General Internal Medicine, San Francisco Veterans' Affairs Medical Center, Department of Medicine, UC San Francisco, San Francisco, CA.
Purpose: Although the use of hormone replacement therapy by postmenopausal women has beneficial effects on osteoperosis and possibly cardiovascular morbidity and mortality, estrogen use also has been linked to the development of cancers of the breast and endometrnim. We sought to determine if an association exists between postmenopansal estrogen use and the development of epithelial carcinoma of the ovary, another hormone-sensitive organ.
Methods: A literature search of the MEDLINE database was performed using the MESH headings estrogen replacement therapy and ovarian neoplasm. Additional studies were found by searching bibliographies and consultation with experts. Twenty-two relevant articles were identified. Two independent reviewers evaluated each article for adherence to inclusion criteria (studies adjusting results for age, postmenopausal estrogen use, outcome of ovarian cancer or ovarian cancer death; women with bilateral oopimrectomy were excluded) and abstracted relative risks of disease and 95 percent confidence intervals. Eight articles representing 19 independent studies were included. These data were used to calculate summary relative risk estimates for the development of ovarian cancer with ever use of postmenopansal estrogens and for increasing years of use.
Results: The summary relative risk for the development of ovarian cancer among ever users of hormone replacement therapy was 1.16 (95% confidence interval [CI], 1.05-1.27) when compared to never users. Any use of -> 2 yrs was associated with a relative risk of 1.20 (95% CI, 1.01-1.42). The summary relative risks for increasing duration of use were: < 1 yr, 1.12 (95% CI, 0.92-1.36); 2-5 yrs, 0.95 (95% CI, 0.76-1.19); 6-10 yrs, 1.07 (95% CI, 0.83-1.38); and > 10 yrs, 1.35 (95% CI, 1.03-1.76). There was no statistical evidence of heterogeneity among the studies.
Conclusions: Prolonged use of estrogen therapy by postmenopansal women may be associated with a small increased risk of developing epithelial carcinoma of the ovary. Women at high-risk for developing ovarian carcinoma may choose to consider this potential risk when deciding whether to use hormone replacement.
CHARACTERISTICS AND OOTCOMES OF ADULT DIABETICS. hiM Goei, DH Hickam. VA Medical Center and Oregon Health Sciences University, Portland, Oregon.
Glycemic control is a commonly used indicator of quality of care in diabetes mellitos, but the relationship between blood sugar measures and other health outcomes has not been well studied in older diabetic populations. We conducted a retrospective cohort study to evaluate the correlations among giycemic control, patient factors, and mortality in adult diabetics. The study was conducted at a large urban VA medical center. The cohort consisted of all patients who had a diabetic medication prescribed and had at least two hemoglobin A le (HgA lc) measurements dunng 1990 to 1995.
There were 1551 patients enrolled hi the cohort. The VA hospital computer system was used to construct a database for these patients that included demographic, appointment, laboratory, and pharmacy records for the years 1990 through 1995. Patients who had less than four years of follow up were excluded. Two groups from the cohort were defined based on glycemie control. The 417 patients in the well controlled (WC) group had mean HgA lc measurements of_< 7%. The 234 patients in the poorly controlled (PC) group had mean HgAIe measurements of>_ 9%. The total number of HgA lc measurements during 1990 to 1995 averaged 8.3 in the WC group and 10.8 in the PC group. The mean age oftbe WC patients was significantly higher than that of the PC patients (70.0 years vs.62.7 years, p<0.001). The WC patients were also significantly more likely to be retired (77.3% vs. 54.9%, p<0.000 I) and mamed (61.1% vs. 52.g%, p=0.05) compared to the PC group. Mortality was 33.8% in the WC group and 1 g.g% in the PC group (p<0.0001). Using logistic regression analysis we found that only age and marital status were significant predictors ofbehig classified as WC. After controlling for age, mortality was still significantly higher in the WC group.
We conclude that, in this population, older man'ied diabetic patients tended to have hotter glyeemic control. Good diabetic control was not associated with longer survival in this population. Hemoglobin A I c measurements appear to be a poor predictor of health outcomas in older diabetic patients. Purpose: The spectrum of HIV severity varies from asymptomatic disease to severe illness and ultimately death. Patients progress through various stages with differing duration and response to therapy. To date there are eight different published HIV prognostic scales. We evaluated the scales based on methodofugic criteria to determine clinical relevance and utility.
Methods: The eight scales were identified by a Medline literature search using the terms HIV, prognosis, survival, severity, mortality, and/or staging. The first line criteria for evaluation were study design, zero-time (ie. well-defined starting point), incinsinn/exclusion criteria and outcomes. Second line criteria pertained to issues of predictive validity, scale elements and simplicity of use.
Results: Of the eight scales identified, seven met first line criteria for methodologic review. The CDC scale is a non-hierarchical, non-predictive model for HIV disease and was not studied further.
The Walter Reed and WHO scales did not meet any major criteria. The Immunologic Staging System (ISS) was non-comprehensive and thus could not include all HIV+ patients in validation sets. The Rabeneck and Royce scales had limited predictive validity The Turner scale performed well, but as defined by its authors, is limited to inpatient analysis. The Justice scale performed best overall. Of note, none of the scales included either CD4% or any psychosocial parameters.
Conclusion: We propose that new scales need to be created for HIV disease that are clinically relevant and applicable to outpatient practice. They should reflect current diagnostic and therapeutic modalities. New parameters could include CD4% (as opposed to absolute CIM count) and psychosocial markers (ie. depression, social isolation) which have been demonstrated to predict survival and/or progression to the Acquired Immune Deficiency Syndrome (AIDS).
NATURAL HISTORY OF PROSTATISM: UROLOGIC COMPLICATIONS IN COMMUNITY-DWELLING MEN. SJ Jacobsen. DJ Jacobson, CJ Girman, RO Rubens, T Rhodes, HA Guess, MM Lieber, Mayo Clinic, Rochester, MN.
Benign prostatic hyperplasia (BPH) and its associated signs and symptoms have a pronounced negative impact on the quality of life of aging men. Unfortunately, most information about the occurrence of urologic complications of BPH has been derived from clinical series of patients seen in referral centers where the mix of patients may nut reflect those from the community at large. In hopes of filling this void in knowledge, we undertook a study in 1990 to determine the natural history of BPH in a population-based, community-dwelling cohort of men.
A cohort of 2115 men ages 40 to 79 years was randomly selected from an enumeration of the Olmsted County, Minnesota population (55% response rate). These men completed a previously validated baseline questionnaire that assessed symptom severity and voided into a portable urometer to measure peak urina~ flow rates. A one-quarter random subsample underwent transrectal sonographic imaging of the prostate to determine prostate volume. Followup was performed through a retrospective review of community medical records to determine the occurrence of acute urinary retention and other urologic outcomes in the subsequent four years.
During the 8,344 person-years of followup, 57 men had a first episode of acute urinary retention (incidence = 6.8/1,0{30 person-years, 95% confidence interval = 5.2, 8.9). Kidney stones occured with similar frequency (n=50, incidence = 6.0/1,000 py) but hydronephrosis, acute renal failure, and urethral strictures were much less common (0.6, 0.9, and 1.8 per I000 py, respectively). Among men with moderate to severe symptoms at baseline (American Urological Association Symptom Index score of> 7), the incidence of acute urinary retention was 3 times greater than men with none to mild symptoms (95% CI=2.0, 5.5). Similar increases in risk were observed for baseline peak urinary flow rates and measures of prostatic volume. Acute renal failure and strictures were twice as frequent in men with moderate to severe symptoms, but these differences were not statistically significant. Kidney stones were equally frequent in men with or without symptoms.
Lower urinary tract symptoms, depressed peak urinary flow rates, and enlarged prostates are all associated with an increased risk of acute urinary retention in community-dwelling men. These measurements may also be predictive of other urologic outcomes, but many of these were too rare to afford adequate power in this cohort. Nonetheless, these findings suggest that the presence of impaired urologic function may herald urologic complications in community-dwelling men. Backgrotmd. The use of injectson parapbemalia is a major route for transmission of human inununedefciency virus (HIV) in the United States. Insulin needles are a potential source for at-ink patients. We undertook a study to assess physicmn and phammcist athtades regarding insulin syringe abtt~e (ISA) We also were interested in altitudes regarding prefilled insulin injec'flcm systems with respect to ISA Methods. A descriptive study of pbysicians and pharmacists who practice in Pfuledelphia was undertaken between March-May 1996. One mailing was unlized, with aresponse rateof25%in ear, hgroap(119 physician responses; 87 phatraacist responses) Phyalciam were further analyzed by stir-described specialty Participants in both groups were randomly chosen from hsts obtained from the Philadelphia County Medical Society (pbysicialts) and Pennsylvadia Department of Health -Ffuledelpfua Cotmty (pharmacists). Questinea were similar for both groups, focusing on three areas: l) insulin syringe diversion, 2) p resc tibwg/dis pensing of free needles and syringes in general and for diabetics in parbcular, and 3) pereepltons of prefiged wsulin syringe systems. Participants were asked to agree/disagree with various statemmts on a 5-point Liken scale. Result between groups was analyzed using the student's t-test
PHYSICIAN AND PHARMACIST PERSPECTIVES OF INSULIN SYRINGE ABUSE IN
Results. Both groups responded similarly to all quest:one. Pharmacists were more likely (i)<.05) tun physicians to agree with the statement that individuals should be able to receive flee, cont~alled quaaimes of needles or syringes. Phamm~ists mdicated ~at they weTe being asked to ~ what they felt were excessive quantities of needles and syringes Both groups disagreed that individuals should be able to receive free r,r or syringes or that giving rr drug users needles or syneges would decrease the spread of the acquired immune deficiency syndrome (AIDS) Pharmacists were more aware of the existence of prefilled syringe systems, and were more likely to agree that prefiged insulin gnmge systems would reduce the diversinn of insulin needles ~nd syringes Within the physician group, there was almost uinversal rr of prefiSed insulin syringe systems by ~adocrinoleglsts, with much less recogmion by emergency room and pnm~ care physicians.
Conulustom Although physiciansandpharmacistsdemonstrateaconcemmgardingISA, pharmacists ate more concerned about excessive prescriptmas nod requests for needles and syringes. Prefilled syringe systems are still unknown to large groups of pbysiciam. Fharmaaists inthcate diat their use for diabeucs requiring insulin may be a way to reduce the risk of insulin syringe diversion in ingh-mk communines.
PREVALENCE OF DERMATOLOGIC MANIFESTATIONS IN HIV-INFECTED
PATIENTS AT PRIMARY CARE PRESENTATION. KK Jhamb, P Muz, KA Freedberg, A Suwanchinda, JH Samet. Section of General Internal Medicine, Department of Dermatology, Boston Medical Center, Boston University School of Medicine, Boston, MA Purpose: To determine the prevalence and range of dermatologic disease in HIVinfected patients at primary care presentation. Methods: A dermatology fellow performed a complete skin and mucous membrane examination on a consecutive series of 95 of 96 eligible patients at presentation for HIV primary care at an urban hospital between 6/95 and 11/95. Clinical diagnoses of all lesions were recorded. In addition, demographics, HIV risk factors and CD4 cell counts were obtained. Results: Patient characteristics were the following: 76% male, 36% white. HIV risk factors were 63% injection drug use, 23% heterosexual, and 14% gay males. The mean CD4 cell count was 312/mm 3 (SD=255). Overall, 87% of patients had at least one dermatologic lesion, and 60% had two or more. The five most common dermatologic diagnoses were oral hairy leukoplakia (OHL) (21%), fonicniitis (19%), xerosis (17%), tinea pedis (15%) and oral candidiasis (13%). The three most common dermatologic diagnoses, in order of frequency, for patients with CD4 cell counts _< 200/ram 3 were OHL, oral candidiasis and tinea pedis, and for CD4 cell counts > 200/ram 3, folliculitis, OHL and xerosis. Kaposi's sarcoma and psoriasis were identified in only one patient each. Conclusions: Dermatniogic problems are exceedingly common in patients on presentation for H]V primary care. Physicians should be alert for oral lesions, fangal disease, dry skin and folliculitis. Although many of the mucocutaneous lesions found were minor, they are often treatable or of prognostic significance. A thorough dermatologic examination should be completed on all patients presenting for HIV primary care. Although alcohol abuse is considered a risk factor for developing community-acquired pneumonia (CAP), its effect on outcomes and processes of care in patients with CAP is less certain. To determine the impact of alcohol abuse on CAP outcomes and processes of care, we analyzed data from 1325 inpatients (pts) with CAP enrolled in the Pneumonia PORT mulficenter, prospective cohen study. Alcohol abuse or dependence (ALC+) was de freed in pts who: I) were current drinkers, and 2) had a CAGE score of>_ 2 or medical record documentation of alcohol abuse or dependence. Vital status and morbid complications were evaluated at 30 days. Length of stay (LOS) and ICU use for the index hospitalization were assessed by review of medical records. Baseline illness severity was calculated using a wall-validated pneumoniaspecific severity index. The ]41 (10.6%) ALC+ pts were younger (mean age 53 vs. 66 years, p<0.001), more often male (78% vs. 49%, p<0.001), less ofen white (77% vs. 88*, p<0.001), had fewer comorbid illnesses (median comorbid illnesses 1 vs. 2, p<0.001), and were less severely ill at presentation (median predicted probability of death 2.2% vs. 3.7%, p<0.00I) than the 1184 ALC pts. Although ALC+ pts had lower 30-day mortality (3.6% vs. 8.4%; p=0.05) on univariate analysis, there was no significant effect of ALC+ on mortality after sO'atificatinn by baseline illness severity (adjusted OR 0.7; 95%C1 0.3-1.7). Overall incidence of morbid complications did not differ between ALC+ and ALC-pts (70% vs. 72%, respectively; p=0.62); however, ALC+ pts had more respiratory failure requiring mechanical ventilation 03% vs. 7%, p=0.02), hepatic abnormalities (24% vs. 13%, p<0.001), thrombocytopenia (12% vs. 5%, p<0.001), GI bleeding (6% vs. 3%, p=0.0g), and encephalopathy (5% vs. 2%, p=0.09) than ALC-pts. In univariate analyses, ALC+ pts had higher ICU use 09% vs. 12%, p-0.02) mad longer LOS (median 8 vs. 7 days, 1:m0.43) than ALC-pts. After adjusting for pt demographics, baseline illness severity, and comorbidity with multivariate regression analyses, ICU use remained significantly higher (adjusted OR 1.9; 95%C1 1.0-3.4) and LOS 9.5% longer (p-0.26) in ALC+ pts. In conclusion, ALC+ pts with CAP had an increased incidence of several specific morbid complications and a higher ICU utilization rate despite younger age, less comorbidity, and lower illness severity at presentation. Although alcohol abuse was not an independent predictor of mortality, these findings suggest that alcohol abuse is an important prognostic factor for physicians to consider when caring for pts with CAP. Methods: 1114 patients seen at VAMC Dallas for preoperative cardiac risk assessment or patients with known cardiac problems were enrolled. Preoperative evaluation included a complete history, physical examination, complete blood counts, SMA 7, erentinr phosphkinase (CPK) with isoenzym~, chest x-ray, and electrocardiogram (EKG). Specific risk variables elicited were: age, history of myoenrdia infarction 0all), canadian cardiovascular society angina (CCSA) class, unstable angina (USA), stable angina, CHF, pulmonary edema (PE), critical aortic stennsis, non-sinus rhythm, premature atrial contractio~_s (PACs) with sinus rhythm, > 5 premature venta'ienlar contractions (PVCs) at anytime, poor general medical status as defined by Goldman and Delaky indices, diabetes realhtus, hypertension, peripheral vascular disease (PVD), cerebrovaseular disease (CVD) and urgency of surgery. Postoperatively, clinical examination, EKG, CPK with isoenzymes were performed daily until day 6 or the day of discharge whichever was earlier. Serial EKG-s and enzymes were done if any indication of cardiac complication developed. Endpoints measured were MI, cardiac death, pulmonary edema, CHF, acute coronary insuflicieney and ventricular arrhythmias.
Results: In a univariate analysis the variables predictive of any cardiac complication were MI > 6 months, emergent surgery, poor g~neral medical status, MI < 6 months, CCSA class III, pulmonary edema ever, CCSA class IVand USA (Fisher's exact test, p< 0.05). By stepwise logistic regression analysis bed-ridden status, CCSA class Ill, MI > 6 months, MI<6 months, emergent surgery, presence of non sinus rhythm or PACs with sinus rhythm or > 5 PVCS at anytime and hypertension were independent significant predictors (p< 0.05 Purpose: Intermittent clandicatinn (IC) is dafmed as exertional lower leg pain which does not begin at rest and which subsides within ten minutes of rest. IC has been considered the most common manifestation of peripheral arterial disee.se (PAD). Recent data from epidemiologic studies suggest that many men and women with PAD do not have symptoms typical of IC. It is unclear whether those without IC are asymptomatic or have other non-classical types of leg pain. We describe the range of leg symptoms reported by PAD patients identified from a blood flow laboratory (BFL) and compare them to leg symptoms reported by patients with atherosclerosis in the coronary arteries (CAD) and no history of PAD. Methods: Consecutive patients diagnosed with PAD in the BFL and consecutive patients diagnosed with CAD in the cardiac catheterization laboratory at an academic medical center were telephoned and interviewed for medical history and leg symptoms. Severity of PAD was determined based on the ankle brachial index (ABI) performed in the BFL. Results: A total of 190 PAD patients and 109 CAD patients were interviewed. As compared to CAD patients, PAD patients were older (68 vs. 63 years, p<0.01), inehided a higher proportion of women (43% vs. 25%, p<0.01), current smokers (17% vs. 8%, p=0.03), and diabetics (41% vs. 14%, p<0.001). Sixty-seven percent Of PAD patients vs. 19% of CAD patients reported exertional leg pain (p<0.001). Just 30% of PAD patients vs. 13% of CAD patients had symptoms consistent with IC (p<0.001). Among all patients with exertional leg pain, PAD patients were more likely to state that their symptoms occurred when they walked up-hill or hurried (84% vs. 65%, p-0.03) and more likely to have exertional pain located in the lower leg (80% vs. 57*/*, p=0.02). PAD patients with an ABI _> 0.9, consistent with non-compressihle vessels, were significantly lass likely to have exertional leg pain than PAD patients with an ABI < 0.9 (50~ vs. 73%, p<0.01). In logistic regression analysis controlling for age, sex, race, and atherosclerotic risk factors~ an ABI level < 0.4 was associated independently with exertional leg pain as compared to patients with an ABI level >_ 0.9 (odds ratio = 16, p<0.01). Prior lower extremity revasenlarization was associated independently and inversely with exertional leg pain (odds ratio = 0.36, p=0.01). Conclusion: Many PAD patients have exertioaal leg pain other than IC. Exertional leg pain in PAD correlates strongly with the severity of lower extremity arterial obstruction. Clinicians may need to be more aware of nonclassical leg symptoms in PAD patients. Congestive heart failure (CHF) is a common medical condition associated with substantial medical expenditures and significant mortality. Framingham Heart Study (FHS) subjects diagnosed with CHF were analyzed to identify trends in hospital use and outcomes. The FHS, a population-based study, began in 1948 with an original cohort of 5209 subjects who have been followed biennially. This report is based on 407 CHF cases between 1950 and 1990, with follow up through 1992. Uniform clinical criteria were used to ascertain CHF since the FFIS inception. Hospital records data were abstracted using a formal protocol. Logistic regression and survival analyses were earned out to investigate the explanatory variables age, gender, myocardial infarction, hypertension, diabetes mellitus and smoking as predictors of death at first hospitalization with CHF and recurrent hospitalization.
RESOURCE UTILIZATION BY CONGESTIVE HEART FAILURE SUBJECTS: EXPERIENCE FROM THE FRAMINGHAM HEART
Nine of the 407 subjects had no hospitalizations. Of the 398 remaining subjects 51% were male, mean age at diagnosis was 72 years (+/-I I sd) and prevalence of myocardial infarction, hypertension and diabetes mellitus was 40%, 83%, and 27% respectively. The median survival time from the time of diagnosis for the 407 subjects was 20 months while that for those who survived their first hospitalization with CHF it was 34 months. Of the 22% who died during their first hospitalization with CHF, 86% of deaths were due to cardiovascular causes. Logistic regression analysis identified myocardial infarction as the only significant predictor of death at first hospitalization with CHF, carrying twice the risk of death when adjusting for age, gender, hypertension, diabetes and smoking (OR = 2.26, p=0.0113). Of the subjects who survived the first hospitalization, the median number of hospitulizations until death or end of follow up was 3 per subject (range 1-32); this did not change over the 4 decades studied (p=0.94). The median time to recurrent hospitalization was 9 months. Proportional hazards regression yielded age as the only significant predictor of recurrent hospitalization (p--O.0001).
In conclusion, CHF is associated with significant mortality during the first hospitalization. Despite medical advances in the treatment and prevention of iscbemic heart disease and hypertension, the median number of hospitalizations has not decreased over the forty years studied. While much h~a been written about the impact of genitotmnary (GU) symptoms on the lives of older men, the literature is sparse regarding similar symptoms in youngnr men. To explore the prevalence of bothersome GU symptoms in younger men who visit their prmmry care physicians we conducted a smwey and chart review study in 1996 at a hosptial-ba.~d general medicine practice, While waiting to visit their prmmry care physicians for any reason, 106 men age 18-50 were approached (5 refused) to complete a brief, self-edmtaistered, pretested survey in a private setting which included a validated urinary symptom instomaent (the American Urological Association (AUA) Symptom Index), a validated GU bother instmmant, questions about prostatitis symptoms (genital/perineal pain and sexual dysfunction) and about a history of GU diseases. Presence of GU symptoms was defined a priori as either: 1) AUA score >7 (moderate to severe urinary symptoms); 2) bother score >1 (more than "a little" bother); 3) "yes" to a question on whether symptoms were bothersome enough to discuss with physician that day; 4) response of "fairly often" or greater to any one of the 9 GU ~ or sexual dysfunction questions; or 5) at least 3 "rarely" responses to these questions. Men with GU symptoms had their outpatient records reviewed for information perraming to the content of the physician visit that followed the survey. Physicians were not privy to their patients' stawey responses.
Of the 101 respondents (mean age 36; s.d. = 8), 52 (51%) had current GU symptoms. Of these men, 25% were bothered by their symptoms and 17% wanted to talk about them with their physicians, Despite their young age. 21% were worried that titeir GU symptoms might be due to prostate cancer. Over one quarter (27%) of all men reported a past history of at least one GU disease and 17% had more than one including: sexually transmitted disease (19%), minary tract infection (10%), urethritis (6%), prostatitis (4%), epididymitis (4%), and benign prostatic hypeqflasia (1%). Chart review for the 52 men with symptoms revealed documentation of GU symptoms in only 23% of cases and an abnormal GU examination in 8%. One third of reviewed charts doctmaeated a GU problem that visit. A broad spectrum of GU diagnoses was documented by physicians, but no one cause predominated. Regardless of whether they had any GU symptoms or pother, 90% of men surveyed thought that ix'unary care physicians should routinely ask younger men GU questions as part of their general health care.
The stuprisingly high prevalence of bothersome GU symptoms and diagnoses in men < age 50 suggests that more information about the clinical, functional, and quality of life implications of these symptoms needs to be collected in this population.
PATrERNS OF FUNCTIONAL LIMITATIONS IN PATIENTS WITH MODERATE
ASTHMA. CAMancuso, MECharlson. Comell University Medical Center, New York, NY Our objective was to document the patterns and severity of patient-specific fmsctioanl limitations due to asthma in a cohort of socio..demogr~hianlly diverse urban patients. Traditionally, days lost from school or work have been reported as indicators of asthma impact; we hypothasizod that limitations are greater when measured by more sensitive patient-specific indicators.
A total of 100 ambulatory patients with moderate asthma wore interviewed at the time of their visits with their primary care internists. Using the Asthma Quality of Life Questionnaire patients were asked 1) to cite 5 activities in which they were limited because of nsthma, and 2) to rate the degree of limitation during the past 2 weeks according to a 7 point ordinal scale ranging from 1 "totally limited" to 7 "not at all limited". Patients were also asked to ratz how active their asthma was during the current period and how satisfied they were overall with the status of their asthma.
Patients had the following characteristics: mean age 40 years (range 19-60); 83% women; 16% white, 38% African-American, 37% Hispanic; 27% finished oollage, 33% had some college, 13% fmished high school, 27% had some high school or less: 33% working full or past-time, 28%
onernployed, 28% hongmaker, 10% stucl~t. Patients cited 33 different activities in which they were limited because of asthma, which were then grouped into categories. The percentages of patients in each category were: 77% climbing stairs, 68% social activities, 66% housework/home maintenance, 58% walking/mobility, 51% sperla/exercise, 32% sleeping, and 18% working /school. Overall, patients' degree of functional limitation on the 7 point scale was a mean of 3.3 (range 1.3-6.6), corresponding to "very limited". Degree of functienal limitation was significantly related to patients" reports of cun'enf asthma activity (p=.05). Patients' overall satisfaction with their asthma status was 17% satisfied, 25% neutral, 5g% dissatisfied. Dissatisfied patients tended to have greater limitations (p= .03), and more active asthma at the time of the interview (p=.001).
Ambulatory patients with asthma suffer multiple diverse functional limitations that are specific to their lifestyles and daily needs. Physician awareness oftbe prcvahame and patterns of patientspecific limitations is critical in targeting interventions and momtoring success of trentment. University, S~ NY. Cetmseltag palients with alcohol related problems can redu~ siOg days, wurk lest, and r impar on health related vanablas such as liver funeriou tests and bypcRenalolL Tbe~ patients pgeseat early in the course of their disease fef ~ care so curly ule~/fftearion of ak:ohol aboso (~) mteaocenrmthissetting. Dascriptersofthispolmlationarepourlydafin~ We now report en the chaescteristies of alenhol abusers ~g in a prmaary enre setling Methods: Patients presenting for prtmarysareat7chnicsiresinthePittsburgharenw~easked to complete a Life~yle Questioanmre which indeded qnsstions about di-inking habits. SettLng$ inchalad privateprecficeg~onp~ maengndbealthenresystems, andVActin~. AA was dafmed as either a score of > g en tbe Aloohol Uso Disurdcrs l&mtifioRien Test (Aedit) OR an qnsntity/fn~qnency rsngc (Q/F) >4 stendard d~n~ >4x/wk in men and 3 stsndard drinks > 4x/wk in wom~ All patitm~ somang pomtive were eamid~ed te be at Isast hasardans drinkers; alenbol depemknee was ant assessed by the screening msmm~t. A11 patients were anked to ~mplete basic demographic date.
Resutts: A total of 6635 patients competed the mreening qanmmminre. 741 purisms (11.2%) were idantified as AA. The Aedit and Q/F idenrified different sabst~ of the populmion: 98/741(t3.2%} wea~onlyQ/F + and302/741 (40.6%) wereonly Aodil+. Males were 2.7X mnse likely to drink in this rangn ( 15.8% vs 5.9%, p<.00r 1 ). Subjects in the 22-30 age renge ~t~re mest likely te be AA (17,6%). but sub~ evar agn 60 had ass 8.5% in~de~ of AA al~l ~,re ~nst likely to be Q/F + only (20.5% ~ mean of 13.2%). Minority paffalations were also mole to be AA (12.9% vs 10.6%, V=0.017). Educational level fur tread was also a algatficant predictor of AA wi~ lower ,~h~a~'oml le~ls being at greater risk (1~.033). Unemployed/disebled subjr employed/retired/studm~ subjects (19.1% vs 10.8%, P<.00OI). Ofnet~ emplo3~d/r~ired/samimus were twine as likely as disabledhmanxployed te be Q/F + only ( 14.4% vs 6.6%) Q~.tme~: /t.A is eammon in the immaty sate setting and is really idanliBed with cenvaniem scre:nmg taswmsents. Significant predictors of AA include male sex, minority race, lower edegatinanl level, andbeingunempfuyed/disabled. Patientsofanyagearealrisk. BothAudit andQ/Fqucsriensare ~ to ider~ify AA, with Q/F boing mest nsfful in older patiems and in employed/retired/~. No national representative prevalence data on physician assisted death is available to inform the debate on policy and legalization in the U.S.
Methods: A stratified sample of 3100 physicians from the AMA Maaterfile received a mailed questionnaire querying their experience with patient requests for assisted death (PAD), frequency of requests refused and acceded to, and characteristics of physicians and patients involved in such requests. Re-mails and telephone prompts wore used to maximize response rate, Results: Initial response rate was 45% ofthoso surveyed, Respondents were 79% male, 55% under age 45, and 900 spent more than half their time in direct patient care. 9.4% were willing to participate in PAD now, while 39~ were willing if legalized. 16.3% reported at least one request for PAD. 2.2% reported at least one experionce with writing a prescription for purposes of PAD and 2.7% reported giving at least one lethal injection. 75% of these requests were patient initiated and 60% were explicit. Leading diagnoses among requesturs were cancer (40~ HIV-AIDS (19%), neurological disease (19~ and organ system failure (22%). Leading reasons for patient requests included loss of dignity (69O/0), discomfort (64%), loss of meaning (56%), fear of ancontrollable symptoms (49%), actual pain (45%), and dependency or being a burden (42%). The primary physician reason given for honoring requests was untreatable symptoms.
Conclusions: A national probability sample of U.S. physicians reported a prevalence of 2.2% for writing a prescription and 2.7% for lethal injection, for purposes of hastening doath. Discrepant analysis will aimoat always overestimate the sensitivity and specificity of NEW test. The bias arises because results concordant by AS and NEW may be concordantly erroneous (i.e. b0~ false positives). Since the GS test is not used to classify these samples correctly, these misclaasifi~tian errors are not identified Consider the following example. An AS test with sensitivity = 0.75 attd specificity ffi 0.97 is used for initial testing. If the actual (tr',tr values for sensitivity and specificity of NEW test are 0.90 and 0.97, rnspe~ive[y, after discrepant analysis the mnaaured sensitivity for NEW test will be in the range 0.90 -1.C0 and measured specificity will be 0.97 -1.00. The mad vahins will depend upon the prevalence of disease in the study population and the rate of concordaoco for false positive and false negative results. With a disease prevalence of 10% anti 50% maximal concordances for false positives and false negatives, the measured sensitivity and specificity would be 0.95 and 0.99, respectively, thus overestimating both parameters.
Apparently successful discrepant analysis can inad to significant and clinically importam overestimation of the sensitivity and specificity of diagnostic tests. This overestimation can have significant consequences, particularly in screening situations where large numbers of false positive results can occur. Discrepant analysis should be ~ cautiously and should not be the sole basis for approval of new tests by the FDA. Objectives: To a.~e$ the perc~rltagr of benzodiazepines (BDZ) consumers in an ambulatory care center and which are the BDZ most frequently employed Design: Retrospective, descriptive study based on medical records. The records were reviewed by one of the inveatigators (R. Mejla or M.Vegn) for any reference for regular con.~arnption of BDZ.
BENZODIAZEPINES CONS~ION IN THE AMBULATORY SETTING IN BUENOS AIRES
Setting: Private Geneva[ internal Medicine Group Practice at Buenos Aires, Argentina Patients: 723 adult patients, who were seen from 6/1/95 to 3115/96, affiliated to e.~ HMO identified with upper middle social class The clinical recorda were randomized according to the first letter oftbe patient's tmmame and grouped eaw.ording to sex and age in four groups.
Results: 21% (54) oftbe 265 mnit~ consume BDZ, this sample was stratified for analysis accord&rig to age in four groups: I under 45 years (136 patients). II 45-54 years (50 patiems), 1B 55-64 years (20pntiemts) and IV older thaa 65 years (52 patiems), the BDZ consumption by each ~'oup was 40 (9%), I30 (26%), t3 (65%0), 17 (33%)r~pactively.
25% (150) of the 458 women consume BDZ, group I: 224 patients, H: 69 patients, BI: 61 patients, IV: 111; the BDZ consumption par [p-oup was 42 (W/e), 30 (43%), 23 (38%) and 83(75%) respectively.
The two BDZ mostly utilized were Bromazepan (39. I%) and Alprazoinm (28.2%). Conclusions: The ~trvey reflects high invel of BDZ consumption in both sexes. Under 45 year old there is a sln'filar percentage of BDZ utilization in males and women.
The male consumption pattern shows a peak in the 55 to 64 year old group This may be due to psycbosociM reasons de*lead fi-ont their work environment
The female pattern is ~erized by an increase in comm'eption between the ages 45 to 64, this my be attributed to the dimcultie, in taking care fftmuitaneo~ly of their famLiy and job. Aanther consumption mcrem~t was ~ in woman older than 65 Tiffs may be probably ~butable to: lonalines~ greast number of chronic dit~ses and disabilities, and lower incomes that are ~ooiated with aging There may be a "tranquilizer's culture" at Buenos Aires, fostered by patJems, physinlans and the pharmaceutical industry DOES THE REDUCED BREAST CANCER MORTALITY AFTER MAMMOGRAPHY SCREENING REPRESENT CURE, EARLY DETECTION, OR DISCOVERY OF RELATIVELY 'BENIGN' TUMORS? SY Moody-Avers, CK Wells, AR Feinsteth. Yale University, New Haven, CT.
During the past three decades, the major reduction in mortality from breast cancer in women over 50 has been at~-ibuted to the better use of screening, particularly with mammography. This conclusion is justified if all breast cancers grow at the same rate, but if some grow rapidly vald others slowly, mammogrephy may seem effective only because it detects the slow-growing non-aggressive tumors that migh~ not be found until much later, if at all
To check this possibility, we used the Tumor Regisffy tiles of Yale-New Haven Hospital (Y-NHH) to assemble and review the medical records of an inception cohort of 232 patients with breast cancer. They were first treated at Y-NHH between January I -December 3 l, 1988, and could be followed thereafter for a median of 79.9 months. Of the 232 patients, 99 (43%) were detected by screening mammography. In life-tabin analyses, 94% of the screen-detected group (SDG) remained free of cancer deaths or recmTences, compared with 78% of patients detected from other events (Lo~mk 2P=.0001). This superiority occurred partly because a high proportion of the SDG (92/99=93%) was in the goad-prognosis TNM stages 0,1, and I1A, compared with 93/133 (70%) of the non-SDG (ChiSquare 2P=.001). Even within the same TNM stages, however, the SDG had distinctly better diseasefree survival results than the non-SDG. The stage 0 (carcinoma-in-sire) patients, who all had diseasefree survival, were found mainly (26/3 t =84%) by screening. For patients in TNM stages I and I[A, the "failure" rates of 3% vs 14% (Logrank 2P=.03) consisted of 2 recurrences and 0 deaths in 66 SDG patients vs. 8 recurrences and 4 deaths in 88 non-SDG patients.
The impact of screening mammograpby in reducing mortality may be grossly overestimated because of the e:~poated artifact of e~ly detection, but also because the screening may End a reintiveiy "benign" form of breast cancer that does not spread and kiiI even if left untreated.
DEVELOPMENT OF A DAILy SYMPTOM QUESTIONNAIRE TO MEASURE RECOVERY IN PATIENTS WITH COMMUNITY-ACQLqRED PNEUMONIA. JP Metlay, SJ Atlas, LH Borowsky, DE Singer. Mas.mehusette General Hospitni, Boston, MA.
The aims of the current study were to 1 ) determine the reliability and validity of a self-administered daily symptom qna~ionnake and 2) measure the rates of resointion of symptoms in patients with communityacquired pneumonia (CAP).
This study was conducted as part of a prospective study of a new emergency department protocol for CAP at the Massachusetts General Hospital. Eligible study subjects included all adult patients (age 18-?,4 years) presenting to the emergency department from 4/1/96 to 10/31/96 with an acute infiltrate on chest radiography, symptoms consistent with CAP, and a predicted low-risk of short-term mortality (< 2%). Exclusion criteria included recent hospitslizatioo, current nursing home residence, immunosuppression, and hypoxemla. The main outcome measttves were based on a new five item symptom questionnnire which rates the severity of coagh, fatigue, dyspnea, ntyatgia, and fever. The questionnaires were self-administered on days 0-7,14, 21, and 28 from the time of diagnosis of CAP. The symptom questions were also administered during patient interviews on days 0, 7,14 and 28 in order to assess the questiormalre's reliability. D,~r fullow-up intervinws, patien~ repot ted the frequency of outpatie m visits to pbysisians and assessed their overall health status.
Of the 89 patients who met study eligibility criteria, 73 patients (82%) consented to participate in the folinw-up study. Of these, 71 patients (97%) r~umed the completed symptom qur and are included in this analysis. The mean age of the study population was 52, 440 were female, and 58% were treated in the outpatient setting. The mean intra-cla~s con-alimon coefficient between the results of selfadministered and interview-administered symptom questlonnatres was .7 over the four interview time points (range .5 to .9). The median times to resolution of individual symptoms were 3 days (95% C.I. 2,3) for fever, 5 days (95% C.I. 3,6) for myalgia, 7 days (95% C.I., 5,14) for fatigue, 7 days (95% C.I. 5,21 ) for dyspnea, and 14 days (95% C.I. 6,28) for cough. The median time to resolution of nil symptoms was 28 days. Failure to resolve symptoms by day 28 was a.~ociat ed with both an increased frequency of outpatient physician visits during this time period and poorer overall health status at day 28.
We conclude that our daily symptom questionnaire is a reliable and valid measure of recovery for patients with CAP. Full resolation of symptoms takes at least 28 days in the majority of piments with CAP. Recent papers have reported a reduction in infarct size with regular aspirin (ASA) use, but these studies may not have adequately accounted for confounding by indication. We studied the relationship between the extent of myocardial damage (by peak CK levels) and recent ASA use through detailed personal interviews of hnspitalized patients with acute myocardial infarction (AIVII) to ascertain whether ASA alters AMI severity.
We interviewed 1623 patients with AMI admitted to 45 hospitals between 1989 and 1993 a median of 3 days after admission. Patients receiving thromhelytic therapy (n=584) were excluded from this analysis. Trained interviewers recorded serial CK values and detailed medical histories (including recent medication use) during chart reviews and stroctured face.to-face interviews.
We defiued ASA exposure as the use of any ASA within four days of admissinn, We used linear and logistic regression to model continuous and binary outcomes, respectively. The table shows the geometric means of peak CK levels, unadjusted end adjusted for age, gender, previous history of angina or MI, history of hypertension or diabetes, and use of other cardiac medications. Similiar results were found using the ratio of peak to top-normal CK and a threshold of twice the top-normal CK as outcome variables. In all analyses, ASA significantly reduced infarct size in univariate analysis, but its effect was substantially diminished upon adjusteaent for the presence of previous cardiac disease.
Theso data suggest that, although regular aspirin use may reduce MI severity (as meeaured by peak CK level), this effect is confounded by pre-existing cardiac disease, and the actual effect of regular aspirin use on infarct size is mode*t. Among all Medicare patients hospitalized in Connecticut for AMI during a nine-mcoth I~a'iod in 1992-93, we ccoducteq a retrospective chart review of all patients who died during hospitalization (n=274). Using a previously developed taxonomy of etitical illness, we identified the occurrence and typos of'major' and 'minor' clinical events, the suddenness and expontedi~ess of the events, the mode of death, and othat variables including information on advance directives and code status.
We found considerabhi heterogeneity in the clinical ~ in patients admired for AblI who died during their hospitalization. Nearly half (46%) of our sample had at leas1 one 'major' clinical ev~t prior to death, including setious arrhythmias (33%), major respiratory events (28%), shock (25%), and major changes in mentation (14%). Sixty petcem of these events were suddcu and unexpected. Mode of death (terminal events) were similarly varied, with the majority being setious arrhythmias (52%) and sh0d~ (30%). A substantial p~centage of terminal events (29%) were atso sudden and unexpected, in addition, 80% of this population did not have advance directives at hospital admission. During hospitalization, code status was changed to a less aggressive level in 51% of patients.
Our findings show that cld~ly patients hospitalized for AIvi] follow a variety of diinical trajectories prior to in-hospital death, often experiencing unexpected clinical events and death from noncardiac as well as cardiac causes. These results have important implications for patient care, because understanding the trajectories of these patients may lead to interventions that could improve patient outcomes. In addition, the low rate of advance directives emphasizes the need for counseling in this area. Our findings also have implications for predintive models of ntortality, because many of the major clinical events and deaths were sudden and unexpected in otherwise clinically stable patients. BACKGROUND: Evaluating the possible risk of significant cardiac complications during the perioperative period remains perhaps the most frequent assessment performed by internists and cardiologists on preoperative patients. The most widely accepted risk indices are those developed by Goldman and Detsky. Because our patient population and the range of surgical procedures dor, e at our hospital may be different from the previously studied groups, we attempted to determine the usefulness of applying these indices in our population.
USE OF CLASSIC INDICES IN THE EVALUATION OF CARDIAC RISKS IN NON
METHOD: We studied 101 patients with ages ranging from 20 to 96 years (mean age of 55 years). The patients recruited in the study w~re preoperative surgical patients in whom the general internal medicine consult service was asked to carry out preoperative risk assessment between January 1994 and January 1996. Doaky and Goldman sco~es were determined for each patinm during the Inr evaluation process
The type of surgnry performed as well as the oc, ourence ofany postoperative cardiac complication was determined by chart review. RESULTS: 5 patients (5.~/O) had va.sodar surgery, 23 (22.8%) had orthopedic s'm'ge~, 27 (26.7%) had intratberacic or intraperitoneal surge~, 11 (10.9%) had head and neck saxtgery, 17 (16.8%) had minor stttgnry and 12 patients ( 11 9%) had other major sairgery that could not be classified under any of the subgroups above Surgnry was either dr or cancelled in 6 (5.9%) cases. 83 patients (82.2%) had Detsky scores ranging from 0-5; I6 (I 59%) hod scores ranging from lO to 20 and 2 patients (2.0%) had scores above 20 (30 and 50 respecovely ) 91 patients (90.1%) had Gokhaam scores ranging from 0 to 9 and 10 patients (9.9%) had Goldman scores ranging from 10to 19. 10 patients(9.9%) bed severe postoperative cardiac complications; only I of these 10 patients had Drtsky and Goldman scores abovelO. Of the 18 patients with higher Detsky scores (a score of l0 or more), only l pati~t (5.5%) had a sevexe postoperative cardiac complication.
CONCLUSION Compliance with primary care visits has been touted as a means for avoiding morbid and costly events, yet this effect has not been proven. We investigated predictors of hospitalization for patients with type-ll diabetes (DM) who attend an inner-city academic general medical practice (GMP) affiliated with an urban teaching hospital. Our a priori hypothesis was that, after controlling for patient demographic and clinical characteristics, patients who kept more of their scheduled primary care visits would have fewer hospitalizations. Patients eligible for this study had type [[ DM (age at onset > 40 and no evidence of ketoacidosis or any explicit diagnoses of type I DM) and had visited the GMP at least once in 1990, '91, '92, and '93 . This established the GMP as a regular source of their health care. From an electronic record system with 150 million records over 20 years for 1.5 million patients, we extracted demographic data, diagnoses, drug therapy, lab test results, and visit history. Visit compliance was defined as the ratio of kept GMP visits to total GMP appointments during the year prior to each patient's first kept GMP visit in 1993. The dependent variable was any hospitalization in the 18 months after this first visit in '93.
The 1482 study subjects had been GMP patients for a mean of 14 years. Their mean age was 64 years; 66% were black, and 72% were women. Their mean duration of DM was 7 years. During the 18 month folinw-up period, 432 patients (29%) were hospitalized 855 times for a mean of 6.7 days. Hospitalized patients were older, had more previous ER visits and hospitalizations, more eomorbid disease, but no difference in glycemic control or duration of DM. Mean visit compliance was 72%. Logistic regression identified 9 factors that independently predicted hospitalizations: greater age, white race, lower weight, cardiovascular comorbidity, highest and lowest prior serum potassium, low prior arterial pH, low prior hemoglobin, and visit compliance (reduction of 11% in hospitalization risk for each 10% increase in compliance, 95% CI =5 17%, p= .0002). Model ROC area=0.73.
After controlling for demographics and clinical factors, DM patients who kept more of their primary care appointments had fewer hospitalizations. This should encourage trials ot interventions to enhance visit compliance in order to reduce morbidity and lower costs. Purpose. Poor adherence to antimberculosis treatment is the most important obstacle to tuberculosis control. We sought to identify and analyze predictors and consequences of nonadhereace to antimbereulosis treatment.
NONADHERENCE IN TUBERC~SIS TREATMENT: PREDICTORS AND CONSEQUENCES
Patients and methods. Retrospective study of a citywide incidence cohort of 184 patients with tuberculosis in New York City, newly diagnosed by culture in April, 1991 --before the strengthening of its control program--, and followed through 1994. Follow-up information was collected through the New York City tuberculosis registry. Nenadberence was defined as treatment default for at least 2 months.
Results. Eighty-eight of the 184 (48 %) patients were nonadheretu. Oreater nonadherence was noted among Blacks (unadjusted RR 3.0 [95% CI, 1.1 to 8.6] compared with Whites), injection drag users (RR 1.5 [95% CI, 1.1 to 2.0]), homeless (RR 1.4 [95% CI, 1.0 to 1.8]), alcoholics (RR 1.4 [95% CI, 1.0 to 1.9]), and HIV-infected patients (RR 1.4 [95% CI, 1.1 to 1.9]); also, census-derived estimates of household income were lower among nonadharent patients (p=0.018). In multivariate analysis only injection drug use and homehissness predicted nonadherence; yet 46 (39%) of 117 patients who were neither homeless nor drag users were nonadheretu.
Nonadherent patients took longer to convert to negative culture (254 vs 64 days, p < 0.001 ), were more likely to acquire drug-resistance (RR 5.6 [95% CI, 0.7 to 44.2]), required longer regimem (560 vs 324 days, p <0.0001), and were less likely to complete treatment (RR 0.5 [95 % CI, 0.4 to 0.7]). There was no observed association between treatment adherence and all-cause mortality.
Conclusions. In the absence of public health intervention, half the patients defaulted treatment for 2 months or longer. Although common among the homeless and injection drug users, the problem occurred frequently and unpredictably in other patients. Nonadherence may contribute to the spread of tuberculosis and the emergence of drug resistance, and may increase the cost of treatment. These dam lend support to directly observed therapy in tuberculosis.
DO SYMPTOMS PREDICT CARDIAC ARRHYTHMIAS AND MORTALITY IN PATIENTS
WITH SYNCOPE? JH Oh, BH Hanusa, WN Kapoor. Department of Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA PURPOSE: Patients (pts) with syncope often have many symptoms prior to, during, or after the episode, but no previous studies have evaluated the usefulness of symptoms in identifying high risk pts. The purpose of this study was m determine: I) if symptoms are predictors of cardiac an'hythmias as etiology of syncope and 2) if symptoms can be used to identify pts at increased risk of mortality.
METHODS: From 08/87 to 02/91, we prospectively evaluated pts with syncope from outpatient, inpatient, and emergency department services of the UPMC. Patients were interviewed, charts reviewed, and detailed information on symptoms and comorbidities obtained. Prodrome was defined as having one or more of the 19 symptoms prior to syncope. A cause of syncope was assigned using a previously reported standardized diagnostic criteria. All pts were folinwed at 3 month intervals until 12/92. A Heart Disease Classification (HCD) was developed using the presence of cardiac disease and functional limitations to categorize cardiac eomorbidities [Class 0 (no cardiac disease) to Class 4 (cardiac disease and symptoms at rest)]. Multivariate logistic regression was used to identify predictors of archythmias. Kaplan-Meier curves and Cox proportional hazards model were used to identify predictors of mortslity.
RESULTS: Of the 503 pts who ag~ed to participate, 6 failed to provide needed information. The 497 pts had a mean age of 54 years and 45% were men. Cardiac etiologies for syncope were found in 76 pts (15%) of whom 55 had cardiac arrhythmias. Noncardinc diagnosis was assigned to 245 (49%), and syncope of unknown etiology to 176 (35%). CONCLUSIONS: I) History of ventricniar arthythmias, HDC, and abnormal EKG were predictors of cardiac amhythmins, but the absence of N/V prior to syncope was also a predictor. 2) In addition to HDC and abnormal EKG, the lack of prodrome was e.ssociated with increased mortality. This study shows that symptoms prior to syncope are helpful in predicting the diagnosis and outcome of tbese pts. Although poor peti-operefive giycemic control is hypothesized, on physiologic grounds, to increase the risk of infectious complications, this relationship has not been tested in a clinical setting. To investigate this relationship, we r a non-cmmoncnt, prospective study of a cohort of 200 diabetic adults who tmdetv, cm ooren=y artety surgr at Johns Hopkins from 1990-95. All data were obtained from medical records. Glyecmic control was represented by the mean blood glucose level (from monitor readings made 4 times daily) during the first 36 his post-o F The Charleson Comurbidity Index [CCI] was used to characterize underlying comorbidity aad the APACHEIII score to characterize overall severity of illness.
PERI-OPERATIVE GLYCEMIC CONTROL AND THE RISK OF COMPLICATIONS IN
The mean age was 62 • 11 yrs; 52% were male and 85% were white. Pnst-op glucose level ranged from 121 to 331 mg/dL. The 25tlL 50th, and 75th percentiles were 197, 221, and 247 mg/dL respectively. Patients who developed complications before the second post-up day (n=9), who died in-hnspita] (n--4), or who had incomplete data (n=5) were r Of the remaining 182 patients, 38 (21%) developed complications including wound infections, urinm 3, tract infections, and pneumonias. Compared to patients in the lowest quartile of post-up glucose, those in the highest quartile were 70% more likely to develop an infection (Odds Ratio = 1.7; 95% Confidence Interval [95%CI] 0.56 to 5.16). As expected, patients with greater comorbidity (OR--1.98 per CCI un/t) and longer post-up ICU stay (>48 hrs vs < 24 hrs: ORffi3.4) were also at higher risk (p<.05). Simultaneous adj~t fur age, sex, race, comurbidity, severity of illness, and duration of ICU stay, ruing mukiple logistic regression, sUengthened the graded association between glucose level and infections complications: compared to patients in the lowest glucose quartile, those in the 2nd (ORffil. 1), 3rd (OR=2.0), and 4th quartiles (ORffi3.3) were at progressively higher risk (p for trend = 0.03).
These data suggest that pour peri--opr glycenuc control is a strong, independent predictor of post-operative infectioes complicatioos in diabetic adults. Thns, they support the notion that better purl-operative control should prevent complications in this high-risk group.
D-DIMER TESTING FOR SUSPECTED PULMONARY EMBOLISM: AN OUTCOME STUDY.
A Perrier 1, S Desmarais 2, C Goehring 1 , P de Mcerloose I , A Morabia I , PF Unger I, D SIosman I , A Junod I , H Bounameaux'. Department of Medicine 1, Geneva University Hospital, Switzerland. H6pital Saint-Luc 2, Montreal, Quebec, Canada.
Background: Plasma level of D-Dimer, a fibrin degradation product, is almost constantly elevated in presence of acute pulmonary embolism (PE). Hence, a normal D-Dimer level (below a cut-off value of 500 gg/L by an ELISA assay) may allow the exclusion of pulmonary embolism. We designed a prospective outcome study to assess 1) the negative predictive value of a D-Dimer concentration below 500 tag/L in patients with suspected PE; 2) the safety of withholding anticoagulant treatment from such patients. Methods: 671 consecutive patients clinically presenting in the Emergency Department of a University hospital (primary to tertiary care) for suspected of pulmonary embolism were included. D-Dimer, lower limb venous compression ultrasonography and lung scan were preformed in all patients, pulmonary angiography being done in case of an inconclusive noninvnsive workup. Patients with a normal D-Dimer were discharged without anticoagulant treatment and followed up during 3 months. Results: Prevalence of PE was 29%. On the basis of discharge diagnoses, D-Dimer (using a cut-off of 500) had a sensitivity of 99.5%. Overall specificity was 41%, but it was lower among older patients. Of the 198 patients with low DD, 196 were free of PE, 1 had a PE and one had incomplete information because of loss to follow-up. Thus the negative predictive value lied between 197/198 and 1961198 [99% (95% C1:96.4-99.9) ]. Using a cut-off of 4000 ~ag/L, the overall specifity of D-Dimer was 93.1%. Conclusions: A plasma D-Dimer concentration below 500 lag/L allows ruling Out pulmonary embolism in 29 % of outpatients suspected of pulmonary embolism. Upholding anticoagulation in such patients is associated with a conservative 1% risk of thromboembolic events during follow-up. In addition, levels of D-Dimer above 4000 gg/L may be indicative of pulmonary embolism in selected patients. Purpose: To assess delayed presentation for HIV primary care using CD4 counts and to examine a range of sociodemographic and psychosoeial factors hypothesized to be associated with lower CD4 cell counts at presentation. Methods: We interviewed 203 consecutive outpatients on initial FfiV primary care presentation at two urban hospitals between 2/94 and 4/96. Primary data were collected on sociodemographic characteristics, alcohol and drug use, social support, sexual practices, and medical and HIV testing issues. Bivariate analyses were conducted to assess the relationship of independent variables with initial CD4 cell count. Variables significant in the bivarlata analyses were considered for inclusion in a multiple linear regression model. Resells: Patient characteristics included: 26% women; 44% black, 29% white, 25% Hispanic, 2% other; 73% with highest yearly income < $16,000; 47% injection drug users; and 19% gay/bisexual men. At initial H]V primary care presentation, 37% had CD4 cell counts _< 2O0/mm 3. Median CD4 cell count was 280/ram 3 (mean 320/mm 3, range I -1710/ram 3 ). Six variables significant at the p<O. 10 level in bivariate analysis were entered into a multiple linear regression analysis: gender, number of close friends, partner with HIV/AIDS, voluntary testing, age, and CAGE score. Age (p<0.02) was the only variable which attained statistical significance; older patients had lower CD4 cell counts. In addition, only 14% of the variation in CD4 cell count at presentation could be accounted for by these six variables (RZ=0.14). Conclusion: HIV-infected patients ot~en initiate primary care with advanced immunosuppression. Despite a broad array of sociodemographic and psyehosocial factors hypothesized to be associated with delayed presentation, we could not determine specific distinguishing factors associated with lower CD4 cell counts nor profile an at-rlsk population. Efforts to engage individuals in HIV testing and primary care will need to be broadly focused if progress is to be made with early intervention for H1V-infected individuals.
DEPRESSED PRIMARY CARE PATIENTS EXPERIENCE SYMPTOMS RESEMBLING TRICYCLIC SIDE EFFECTS PRIOR TO INITIATING PHARMACOTHERAPY Bruce L.
Rollman, Marian Block, and Herbert C. Schulberg, University of Pittsburgh School of Medicine, Pittsburgh, PA. Puruose: Adherence to tricyclic antidepressants is often reduced by medication side effects which result in patient discomfort and affect recovery. Among depressed primary care patients, we wished to determine: (1) the prevalence of symptoms attributed to tricyclic medications prior to initiating pharmaco-therepy; and (2) if any symptoms predict medication nonadherence. Methods: 75 primary care patients meeting DSM-II1-R criteria for a current major depression and receiving nortriptyline from trained primary care physicians were assessed for symptoms resembling tricyclic side effects using a three-point checklist (symptoms rated from 0 -"absent" to 2 -"present and causing significant distress"). Assessments were conducted prior to initiating pharmacotherapy and at weekly follow-up visits. Depressive severity was assessed using the Hamilton Rating Scale for Depression (HRS-D). Results: Subjects had a mean age of 39 years, 77% were female, 59% Caucasian, 77% had H.S. education, and 46% were employed; baseline mean HRS-D was 23.8. Dry mouth (48%), dizziness (44%), nausea (39%), tremor (36%), constipation (35%), and slurred speech (21%) were frequently experienced at baseline. Before starting nortriptyline, severely depressed subjects (HRS-D> 20) were significantly (p=0.05) more likely to experience dizziness, nausea, and slurred speech, than less depressed subjects (HRS-D<20). Those dropping out of the acute phase of pharmacotherapy (n=25) were more likely to experience nausea, tremor, and slurred speech at baseline than those completing it (1)=0.05). Conclusions: Symptoms resembling tricyclic side effects are commonly experienced by depressed primary care patients. Physicians should question patients about these symptoms prior to initiating tricyclic pharmacotherapy so as to preclude misa~,ribution of these symptoms. Purpose: To determine the predictors of an abnormal Upper Gastro-Intestiual X-ray (UGI) among inner city, primary care patients with dyspepsia. Methods: We studied 800 consecutive patients sent for UGI to evaluate dyspepsia. We collected baseline data on predictors from the physicians ordering the UGI and from medical records. Three months later we reviewed charts to assess UGI results. Results: Of 659 patients with UGI results, 96 (14.6%) were abnormal (28 ulcers, 6 masses, 25 reflux esophagitis, 14 gastritis, 23 others). Patients with abnormal UGI's were distinguished from normal patients by (all p < .05): age (52 years for abnormals vs 47 years for ttormals), male gender (59% vs 45%), night pain (53% vs 42%), ulcer history (29% vs 22%), speaking English (31% vs 23%), & having insurance (43% vs 32 % ). Using logistic regression, the 3 independent predictors of abnormal UGI's were gender (OR=2.4, 95% CI 1.4-3.9), night pain (OR=2.0, 1.2-3.2), and age (1.1, 1.0-1.1). The area under the curve was 0.71. A dyspepsia score was created from these predictors with likelihood ratios ranging from 0.4 for the lowest scores (sensitivity =93%) to 3.2 for the highest scores (specificity=93%). Use of the rule would have decreased UGI orders by 16 % with a testing threshold of 5 % (probability of disease below which an UGI is not ordered), and by 38% with a testing threshold of 10%. Conclusions: Most patients bad normal UGI's. The dyspepsia score may help screen out low risk patients who could be reassured and treated empirically without an UGI. If validated and safe, this diagnostic tool could create substantial cost savings.
DYSPEPSIA IN THE INNER

CORONARY ARTERY DISEASE AS A RISK FACTOR FOR PROSTATE CANCER. 12l
Bosenber~. A Pablos-Mendez, AI Nougat, Divisions of General Internal Medicine, Epidemiology and Oncology, Columbia University, New York, NY.
Observational studies suggest an environmental etiology for prostate cancer. Both prostate cancer and coronary arte~ disease (CAD) are primarily diseases of industrialized mad affluent countries. While CAD has many known risk factors which are highly prevalent in the Western world, no risk factors for prostate cancer specific to the Western environment have been conclusively identified. Only lipids and dietary fat intake have thus far been implicated. We hypothesized that risk factors for CAD may also be associated with prostate cancer. The relationship between prostate cancer and CAD is explored in a case conUal study.
Using a case-control design, we studied all patients newly diagnosed with prostate cancer at Columbia Presbyterian Medical Center from 1/84 to 12/86 (cases; n=319). This time period was chosen because it predates the introduction of prostate specific antigen (PSA) testing, which would increase the proportion of c~ses with latent prostate cancer which may have different risk factors. Controls (n=189) were patients with benign prostatic hypertrophy (BPH) histologically proven during the same time period. Data on CAD and other variables including race, age, smoking, diabetes and aspirin use were obtained by review of medical records.
Prostate cancer was associated with CAD, Odds Ratio (OR) = 1.86 (1.12-3.09), ~d black race, OR= 2.03 (1.25-3.30). Prostate cancer was not associated with smoking or aspirin use. There was a trend suggesting reduced risk among diabetics, OR=0.60 (0.34-1.06). Adjusting for age, race and diabetes in a logistic regression model, CAD was an independent risk factor for prostate cancer, ORad-usta d = 2.00 (1.1g -3.39), even among cases with stage I prostate cancer, ORadjusted = 2.80 (1.42 -~.51), who are presumed to have latent cancer.
The association between prostate cancer and CAD suggests that the two diseases may share risk factors. Further research into the etiology of prostate cancer should focus on the factors that they have in common. The morbidity and mortality of hepatitis B infection (HBV) is preventable with early use of the hepatitis B vaccine series. Injection drug use is the most common identifiable risk factor for hepatitis B (I-IBV) infection in this county and 50% of injection drug users (IDUs) under 30 have sero-markers for HBV after less than 3 years of injecting. We assessed risk for HBV infection and determined beliefs and prior experiences regarding HBV infection, screening and vaccination in a cohort of young IDUs. Methods: A consecutive sample of young IDUs were interviewed at needle exchange, secondary exchange, and youth outreach sites in San Francisco. Results: Of the 188 eligible, 135 (72%) consented to be interviewed. The median age of IDUs was 22; 72% were Caucasian, 31% female, 52% had not completed high school. There were 3 or more sex partners reported by 65% of participants and 32% of the men had sex with men in the last 6 months. Within the last year 14% of participants traded sex for money or drugs. Of those interviewed, 75% first injected before age 20; had used injection drugs for 5 years and 70% had injected 11-31 days in the last month. Most participants had used for 3 years before accessing a needle exchange. In the previous month 27% shared needles.
Only 13% of young IDUs perceived themselves to be at high risk for HBV infection. Of note, 70% saw a health provider within the last 6 months, but only 44% had ever been tested for HBV and 29% had ever been offered the HBV vaccine. Of the 3-part hepatitis B vaccine series 18% received the first vaccine and 10% had completed the series. Over 70% stated that they would accept the HBV vaccine at the time of the interview. Beta-blockers (BB) have been associated with a reth:ction in cardiac iscbemia and events w~en administered during the early perioperafive period of vascular surgery. Objective: To examine the effects of intraeperative and pe~operative BB use and of pe~operabve BB withdrawaJ on mort~dity aner v~cular surgery. M,~thode: A retrospecUve oohort study of 210 consecutive major vascular surgical procedures at the Ho~llat of the University of Pennsylvania in 1995 yeas performed. Data pe~ioperative BB use, BB discontinuation, clinical risk factors, and postoperative in-hcq3ital mortality were collected. Procedures were carotid endarterectomy (44%), abdominal aortic aneerysm repatr (16%), peripberal arterial surgery (35%) and Other major vascular surgeries (5%). Procedores f~r traumatic injury, bemedialysis access, preud~neu~sm repat r, or those requiring cardiopulmonary bypass wee excluded. Re~lltS: Mortality iecidance ~ 3.8% Postoperative BB use was not associated with a reduction in mortality in muRivanate analysis that adjusted for a history of angina, myouordial infarction (IVY), congestive heart failure (CHF), and diabetes mellitas (DM): multivariate odds ratio (OR) = 0.8; 95% confidence iaterval (CD 0.2, 3.8 The results were unchanged after adjusting for postoperative CHF and excluding paBents receiving BB for ischemi~ Intranperative BB use, however, was associated with a redac~on in mortality in univarlate analysis (0% with and 53% without use of BB, p = 0.054) and in stratified an~yses adjusung for each of the following variables (all P-volues in stranfied analyses ~0 05): age; history of angnia, M], DM, CHF, arrhythmJa, or asthn~ (Multivariate analysis could not be performed because there v, ere no deaths in the exposed group.) The agscc~ation between intraeperative BB and morality was no longer significant when stratified by s~rgery type (p = 0.18), although the numbers in each stratum were very small. The mortality rate in patients who had BB discontinued postoperatively was significantly yeater than in thee who had their BB cordinued (multivariate OR adjusting for history of aegina, Dlvl, Nil, CHF, and postoperative CHF, 56.1; 95% CI: 2.4, 1315). This increased risk persisted after excluding subjects with conditions that might have precluded BB readministration (OR I 8.0, CI 0.9, 363). The results were unchanged after adjusting for surgery type. Conclusion: Intraoperative use Of BB may reduce the risk, and stopping BB postoperatively may increase the risk, Of postoperative mortality in vascular surgical patients. Objective: To determine if HMG-CoA reductase inhibitors (statins) are effective in preventing stroke events in patients at increased risk for coronary artery disease.
Design: Mete-analysis of randomized controlled trials. Data Identification: Clinical trials were identified by a computerized search of MEDLINE, by an assessment of the bibliographies of published studies and metaoanalyses, and by contacting pharmaceutical companies that manufacture statins.
Study Selection: Trials were included in the analysis if their patients were randomly allocated to a statin or placebo group, and reported data on fatal and/or nonfatal stroke events. Eleven of 28 trials were selected for review.
Data Extraction: Data were extracted for details of study design, patient characteristics, interventions, duration of therapy, cholesterol measurements, and the number of fatal and nonfatal stroke events in each arm of therapy. Missing data on stroke events were obtained by contacting the pdmsry authors of the clinical trials.
Results of Data Synthesis: Among 19,285 randomized patients, the rate of total stroke in the placebo group was 2.46% 190% nonfatal and 10% fatal), in contrast, patients who received statins had a 1.72% stroke rate. Using an exact stratified analysis (StatXact 3.0.2), the pooled odds ratio (OR) for total stroke was 0.69 {95%C1:0.56 to 0,85) (p =0.0004L The pooled OR for nonfatal stroke was 0,63 (95%Ch 0,50 to 0,79) (p -0.00001), and the pooled OR for fatal stroke was 1,25 (95%C1:0.71 to 2.24) (p = 0.4973).
Conclusion: The best available evidence suggests that HMG-CoA reductase inhibitors may be useful in preventing the morbidity associated with stroke in patients at an increased risk for coronary events. Data from 11 placebo controlled trials suggest that on average, one stroke is prevented for every 143 patients treated with statins. Beta blockers (BB) have been shown to reduce the incidence of perioperative myocardial ischemia and cardiac events in v-ag'u I ar surgical patients. Objective: To asseu the prevalence of perioperative BB administration, discoatiauBtion or delayed reedministration, and to examine the relationship but'wean BB use and preoperative cazdizr risk rasters. Mathi~: A reucq~ctive cohort study of 210 consecutive vascular surgical procedures at the Hospital of the University of Pennsylvania in 1995 v-as performed. Data were abstracted from medical records regaxdnig risk factors for perioporative cardiac complications, and repealing BB administration in the i~eeparative, intraolperative, and poutol~rative periods. Results: 44% of patients underwent carotid endastereatomy, 16% abdominal aortic aneurysm repair, 35% peripheral arlertal surgery, and $% other major vascular procedures. The preve]e~ce of risk factors were: 48% age > 70, 28% prior myocardial infarction, 33% angina, 33% ululates mellitas, 1.4% ventricular arrhydimia requiring tr~tment. 22% of patients had none of these risk factors (low cardiac risk). 59=/0 had 1-2 risk Factors (intermediate risk), and lg=A had 3 or more (high risk). Frequencies Of BB administration were: 26% preadraissian, 24% preoperative, 33% intrao/~rative, 38% postoperative. Postoperative BB adlmnistration was similar (591154, 38*/,) after excluding thee patients with coat raindications to BB use (oreo~rative history of asthma, chronic oben~ctive pulmonmy disease, bradyarrhytiunia, or preoperative chest xray evidence of congestive heart failure) Of the 62 patients receiving BB preoperatively, 21 (39"/o) did not receive a BB within the first 48 hours after surgery (7 (l I%) had BB discontinued permanemly, and 15 (28%) had a 45 hour perioperative delay in readministration) Preoperative BB use was the strongest predictor Of postoperative BB use (odds ratio (OR) 33, p < O.00I). The level of preoperative risk w~ not assooatod with the use of postoperative BB: OR 1.0, p = 0.9 for those with intermediate versus low risk; OR 1.9, p = 0.2 for those with high versus low risk. Conchisise: A substantial proportion of patients undergoing vascular surgery are not receiving BB in the period of highest cardiac risk, including those at highest risk for cardiac complications, and many patients on BB have them withdrawn during the critical perioperative period. Objective: To assess the effects of detiberately hypotensive epidural anesthesia on the incidence of cognitive, cardiac and renal complicaEons in eldedy patients undergoing elective total hip replacement. The enthusiasm of surgeons regarding potential benefits is countered by internists' concerns mgarding potential risks, especially in elderly patients with comorbid medical disease.
Methods: Randomized controlled trial of hypotensive vs. normotensive intraoparative mean arterial blued pressure (MAP) management. Patients randomized to hypotensive anesthesia had MAPs maintained in the 45-55 mmHg range. Eligibility criteria required either age over 70, or age over 50 plus the presence of cardiac disease, hypertension, or diabetes. Cognitive outcome was assessed by within-patient change On 10 neumpsychological tests from before surgery to 1 week and 4 months after surgery. PmspectNe standardized surveillance was performed fur delirium, thromboembolism, blood loss and replacement, cardiovascular and renal outcomes.
Results: 235 patients undergoing elective primary total hip replacement wee enrolled. The two groups were similar at baseline in terms of age (mean age 72), sex (50% women). comorbidity and cogn~ve function. Post-operatively, no significant differences in the incidence of short-term or Iongterm cogn~ve dysfunction were obsenred between the two different blood pressure management groups, with a power over 99% to have detected a clinically important difference. Them wee no significant differences in the rates of other adverse consequences, including cardiac, renal or thmmboembotic complications. Them were also no differences in duration of surgery~ intraoperatJve estimated blood loss. or transfusion rates.
Conclusions: Elderly patients can safely receive controlled hypotensive epiduml anesthesia using this anesthesia management protocol; however there was no evidence of increased benefit to use of the more hypotensive range. The anticipated high proportion of patients with cardiovascular comerbidity maximizes the generalizability of the results. Age was not a significant independent correlate of CTR.
RISK FACTORS FOR CARPAL T~T
Conclusions: Factors traditionally associated with carpal tunnel syndrome such as diabetes mellitus and hypothyroidism appear to be weak correlates of CTR in older women, while inflar~matory arthritis is a much stronger predictor.
The use of corticosteroids may be an independent risk factor for CTR. One hypothesized reason for lower revascularization rates reported among black men who undergo cardiac catheterization (CATH) compared to whites is that blacks are believed to be less likely to have severe coronary disease. To test this belief, we compared CATH results in black and white men admitted for unstable angina (US) or acute myocardial infarction (MI).
We used discharge date to idenUfy men > 30 years old discharged from 5 VA medical centers between 1011169 and 9/30195 with US or MI, who underwent CATH. We requested charts for all blacks, and a random sample of whites matched on age, diagnosis, VAMC, and year discharged. We verified the cardiac diagnosis using standard clinical definitions. A physician blinded to pace assessed the CATH report for left ventricular ejection fraction (LVEF) and CAD, classified as none (no obstruction over 70%L mild (t-2 vessel (V) without proximal ts~ anterior descending involved (PLADL moderate ( 1-2 V with PLAD) or severe 13V/left main).
Blacks with US or MI were less likely than whites to undergo CATH (51% vs 57%, p < 0.01, X=). Among those with diagnoses confirmed by chart review who had CATH, blacks had less significant CAD (p < 0.01, X z for trandl and similar LVEF. More blacks than whites with US (31% vs 16%i or M1121% vs 8%} had no obstructions > 70% {both o < 0.01. x ~ test).
Black white differences in CATH findings, by discharge diagnosis Severity of coronary disease l%) PURPOSE. Guidelines suggest that deep-vein thrombosis (DVT) should be treated with intravenous heparin for 5-10 days, overlapping with warfarin for 4-5 days. However, there is pressure to discharge patients quickly. We analyzed the effect of the length of hospital stay (LOS) for treatment of DVT on the rate of recurrent thrombosis.
METHODS. We used linked State of California hospital discharge records from 1991 -1994, including linkage to a state death registry. We selected cases coded as having a principal diagnosis of DVT hut without pulmonary embolism (PIE) and without DVT or PE in the prior 6 months. Outcome was hospitalization for DVT or PE within 6 mo. Charts from 2 hospitals were reviewed to validate coding for LOS of 3,4 and >4 days.
RESULTS. Between 1991 Between -1994 ,169 cases hospitalized for 3 or more days met entrance criteria. The percentage of patients with LOS of 3,4,5,6, 7-10 and > 11 days was, respectively, 7.5%, 14.3%, 18.8%, 19.7%, 37.6% and 9.5%. Local audit of DVT cases revealed that 43%, 87%, 88%, and 95% of cases with LOS of 3,4,5 or 6 days, respectively, had documented DVT and were admitted for routine anticoagulation therapy. For LOS of 4,5,6 or 7-10 days, the cumulative incidence of recurrent DVT/PE in the ensuing 6 months was, respectively, 4.7%, 5.1%, 5.8%, and 5.8%. Log rank test of Kaplan-Meier plots revealed a significantly lower rate of recurrent DVT for LOS = 4 compared to LOS =6 days (p < 0.01). In a logistic model, longer LOS was associated with a higher rate of recurrent DVT, controlling for age, sex and malignancy, but without controlling for other potential confounders. CONCLUSION. We found no evidence that a LOS as short as 4 days was associated with a higher rate of recurrent DVT. An undef'med confounder likely explains lower recurrence rate with lower LOS.
EFFECT OF WEIGHT, AGE, SEX, CLINICAL DIAGNOSIS AND THROMBO-PLASTIN REAGENT ON STEADY-STATE HEPARIN REQUIREMENTS. White RH_ Zbou H, Woo L, Mungal( D. University of California, Davis, Sacramento CA and Tallahassee Memorial Hospital, Tallahassee, FL PURPOSE: Although it is known that weight affects steady-state heparin requiremerits, the effects of gender, age, clinical diagnosis, and the specific activated partial thr omboplastin (APT1") reagent used have not been analyzed using multivariate methods. METHODS: We retrospectively analyzed 4 cohorts of patients from 3 hospitals who were treated with IV heparin : 2 with deep-vein thrombosis (DVT) and 2 with corotmry artery disease (CAD). For each diagnosis, half the patients were monitored using the Actin FS reagent and half with Actin FSL. We used the software program Drugcalc to computer model each patient's dose response over 48-72 hours and then predict the steady-state beparin dose required to achieve an APTT ratio of 2.0.
RF~ULTS: We analyzed 340 eases: 165 with DVT and 175 with CAD. Analysis of variance using saturated models with and without terms that included clinical diagnosis revealed that clinical diagnosis was a significant predictor of the heparin dose (p < 0.001), with higher doses needed in patients with DVT. For both DVT and CAD, the thromboplastin reagent used was not a predictor of the beparin dose (p > 0.42). Using linear regression modeling, the steady-state heparin dose needed for patients with DVT depended on weight plus an effect modification term that included weight and age. For patients with CAD artery disease, there was only a weak relationship with weight.
CONCLUSIONS: Heparin dose requirements in patients with DVT and CAD are significantly different; use of the 2 thromboplastin reagents that were studied did not affect heparin requirements. For patients with DVT, accuracy of heparin dosing may be improved by using age as well as weight in selecting the initial infusion dose. Although chest pain is one of the most common symptoms in primary care, most of the evaluated patients do not have cardiac disease. Chest pain that is not typical angina is seldom caused by coronary ischemia and often arises from anxiety, panic disorder, somatization, or culture-bound syndromes. To study the characteristics of chest path and psychiatric co-morbidity, we identified 287 patients, from three primary care clinics in New Haven, who had been referred to the Yale cardiology exercise laboratory during May, 1995 -June, 1996 . By telephone or letter, we were able to reach only 120 patients, of whom 47 Latino, 25 Black, and 15 White patients were eligible and agreed to participate. In semi-structured personal interviews, done in the patient's primary language (either in English or in Spanish), we explored the character and circumstances of the chest pain. We also administered the Rose questionnaire on angina, and the Prime-MD screen for panic and depression. Chest pain was classified as classic angina ifR fulfilled the three "Rose criteria" of (I) substemal or in the left chest and arm, (2) precipitated by effort, (3) relieved whhin t0 minutes by rest or nitroglycerin, and if it was also reproducible and the first symptom experienced on exeninn. The pain was non-anginal if none or only one of the three Rose criteria was fulfilled. Intermediate patterns of pain were called atypical. Clinical outcome at six months afier the exercise test (ETI") wss detennined from the medical record.
IS IT REALLY ISCHEMIC
Among the 87 patients, 65 (75%) had negative ET]'s and no evidence of ischemic heart disease at six month follow-up. When rates of positive tests were determined in subgroups, the ETT was positive in 3/5 (60%) patients with classic angina, but was also positive without suitably explaining the symptoms in 11/44 (25%) of the atypical group and in 8/38 (21%) of the non-anginal group. Both the latter rates of positive ETT were lower in patients who also screened positive for panic disorder or depression, particularly in Latinos with the culture-bound syndromes of Nervios or Ataque de Nervios.
We conclude that most of the patients referred for cardiac exercise testing do not have objective evidence of ischemin heart disease In most patients, a careful clinical history, attention to psychiatric co-morbidity, and particularly in Latinos, awareness of culture-bound syndromes, can identify patients who are unlikely to need or benefit from a cardiac stress test in the work-up of chest pain.
